Literature DB >> 19240081

Sept5 deficiency exerts pleiotropic influence on affective behaviors and cognitive functions in mice.

Go Suzuki1, Kathryn M Harper, Takeshi Hiramoto, Takehito Sawamura, MoonSook Lee, Gina Kang, Kenji Tanigaki, Mahalah Buell, Mark A Geyer, William S Trimble, Soh Agatsuma, Noboru Hiroi.   

Abstract

Deletion or duplication of the human chromosome 22q11.2 is associated with many behavioral traits and neuropsychiatric disorders, including autism spectrum disorders and schizophrenia. However, why phenotypes vary widely among individuals with identical deletions or duplications of 22q11.2 and which specific 22q11.2 genes contribute to these phenotypes are still poorly understood. Previous studies have identified a approximately 200 kb 22q11.2 region that contributes to behavioral phenotypes in mice. We tested the role of Septin 5 (Sept5), a gene encoded in the approximately 200 kb region, in affective behaviors, cognitive capacities and motor activity. To evaluate the impact of genetic backgrounds on behavioral phenotypes of Sept5 deficiency, we used mice on two genetic backgrounds. Our data show that Sept5 deficiency decreased affiliative active social interaction, but this phenotypic expression was influenced by genetic backgrounds. In contrast, Sept5 deficiency decreased anxiety-related behavior, increased prepulse inhibition and delayed acquisition of rewarded goal approach, independent of genetic background. These data suggest that Sept5 deficiency exerts pleiotropic effects on a select set of affective behaviors and cognitive processes and that genetic backgrounds could provide an epistatic influence on phenotypic expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19240081      PMCID: PMC2733818          DOI: 10.1093/hmg/ddp086

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  56 in total

1.  A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice.

Authors:  Noboru Hiroi; Hongwen Zhu; Moonsook Lee; Birgit Funke; Makoto Arai; Masanari Itokawa; Raju Kucherlapati; Bernice Morrow; Takehito Sawamura; Soh Agatsuma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 2.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

3.  COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Stephan Eliez; Tracy Thompson; Christine Hinard; Lauren Penniman; Carl Feinstein; Hower Kwon; Shuting Jin; Booil Jo; Stylianos E Antonarakis; Michael A Morris; Allan L Reiss
Journal:  Nat Neurosci       Date:  2005-10-23       Impact factor: 24.884

4.  Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome.

Authors:  Therese van Amelsvoort; Jayne Henry; Robin Morris; Michael Owen; Don Linszen; Kieran Murphy; Declan Murphy
Journal:  Schizophr Res       Date:  2004-10-01       Impact factor: 4.939

Review 5.  Velo-cardio-facial syndrome: a review of 120 patients.

Authors:  R Goldberg; B Motzkin; R Marion; P J Scambler; R J Shprintzen
Journal:  Am J Med Genet       Date:  1993-02-01

6.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.

Authors:  A Nagy; J Rossant; R Nagy; W Abramow-Newerly; J C Roder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

7.  Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1.

Authors:  Zhizhong Dong; Boris Ferger; Jean-Charles Paterna; Denise Vogel; Sven Furler; Maribel Osinde; Joram Feldon; Hansruedi Büeler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

8.  Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice.

Authors:  Francesco Papaleo; Jacqueline N Crawley; Jian Song; Barbara K Lipska; Jim Pickel; Daniel R Weinberger; Jingshan Chen
Journal:  J Neurosci       Date:  2008-08-27       Impact factor: 6.167

9.  Comparing phenotypes in patients with idiopathic autism to patients with velocardiofacial syndrome (22q11 DS) with and without autism.

Authors:  Wendy R Kates; Kevin M Antshel; Wanda P Fremont; Robert J Shprintzen; Leslie A Strunge; Courtney P Burnette; Anne Marie Higgins
Journal:  Am J Med Genet A       Date:  2007-11-15       Impact factor: 2.802

10.  Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome.

Authors:  Jeffrey M Long; Patricia LaPorte; Sandra Merscher; Birgit Funke; Bruno Saint-Jore; Anne Puech; Raju Kucherlapati; Bernice E Morrow; Arthur I Skoultchi; Anthony Wynshaw-Boris
Journal:  Neurogenetics       Date:  2006-08-10       Impact factor: 3.017

View more
  41 in total

Review 1.  Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.

Authors:  Susan B Powell; Martin Weber; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2012

Review 2.  Application of in utero electroporation and live imaging in the analyses of neuronal migration during mouse brain development.

Authors:  Yoshiaki V Nishimura; Tomoyasu Shinoda; Yutaka Inaguma; Hidenori Ito; Koh-Ichi Nagata
Journal:  Med Mol Morphol       Date:  2012-03-20       Impact factor: 2.309

Review 3.  The emerging functions of septins in metazoans.

Authors:  Juha Saarikangas; Yves Barral
Journal:  EMBO Rep       Date:  2011-10-28       Impact factor: 8.807

Review 4.  The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders.

Authors:  Liam J Drew; Gregg W Crabtree; Sander Markx; Kimberly L Stark; Florence Chaverneff; Bin Xu; Jun Mukai; Karine Fenelon; Pei-Ken Hsu; Joseph A Gogos; Maria Karayiorgou
Journal:  Int J Dev Neurosci       Date:  2010-10-08       Impact factor: 2.457

5.  Septins regulate developmental switching from microdomain to nanodomain coupling of Ca(2+) influx to neurotransmitter release at a central synapse.

Authors:  Yi-Mei Yang; Michael J Fedchyshyn; Giovanbattista Grande; Jamila Aitoubah; Christopher W Tsang; Hong Xie; Cameron A Ackerley; William S Trimble; Lu-Yang Wang
Journal:  Neuron       Date:  2010-07-15       Impact factor: 17.173

6.  Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice.

Authors:  Michael Didriksen; Kim Fejgin; Simon R O Nilsson; Michelle R Birknow; Hannah M Grayton; Peter H Larsen; Jes B Lauridsen; Vibeke Nielsen; Pau Celada; Noemi Santana; Pekka Kallunki; Kenneth V Christensen; Thomas M Werge; Tine B Stensbøl; Jan Egebjerg; Francois Gastambide; Francesc Artigas; Jesper F Bastlund; Jacob Nielsen
Journal:  J Psychiatry Neurosci       Date:  2017-01       Impact factor: 6.186

7.  Septin 14 is involved in cortical neuronal migration via interaction with Septin 4.

Authors:  Tomoyasu Shinoda; Hidenori Ito; Kaori Sudo; Ikuko Iwamoto; Rika Morishita; Koh-ichi Nagata
Journal:  Mol Biol Cell       Date:  2010-02-24       Impact factor: 4.138

Review 8.  Neurobiological perspective of 22q11.2 deletion syndrome.

Authors:  Janneke R Zinkstok; Erik Boot; Anne S Bassett; Noboru Hiroi; Nancy J Butcher; Claudia Vingerhoets; Jacob A S Vorstman; Therese A M J van Amelsvoort
Journal:  Lancet Psychiatry       Date:  2019-08-05       Impact factor: 27.083

Review 9.  Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.

Authors:  Yavuz Ayhan; Ross McFarland; Mikhail V Pletnikov
Journal:  Prog Neurobiol       Date:  2015-10-25       Impact factor: 11.685

Review 10.  Septin functions in organ system physiology and pathology.

Authors:  Lee Dolat; Qicong Hu; Elias T Spiliotis
Journal:  Biol Chem       Date:  2014-02       Impact factor: 3.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.